FDA Warning Letter — Hanlim Pharm Co. Ltd.
The FDA took a Warning Letter action against Hanlim Pharm Co. Ltd. on Oct 2, 2026 (Yongin, South Korea). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Hanlim Pharm Co. Ltd.
- Date
- Oct 2, 2026
- Fiscal Year
- 2027
- Product Type
- Drugs
- Center
- CDER
- Location
- Yongin (South Korea)